Quest Diagnostics Inc $63.21

up +1.26


29/8/2014 04:00 PM  |  NYSE : DGX  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get DGX Trend Analysis - it has underperformed the S&P 500 by 13%

Partner Headlines

  1. LabCorp: A Leading Independent Diagnostic Laboratory

    GuruFocus
  2. Air Methods Navigates To Grow Medical Flight Business

    IBD
  3. Myriad Genetics Guidance Disappoints, Q4 Edges Views

    IBD
  4. Myriad Genetics' Earnings Face 'Angelina Jolie' Comps

    IBD
  5. Bernard Horn Comments on Quest Diagnostics

    GuruFocus
  6. Earnings Scheduled For July 24, 2014

    Benzinga
  7. Analyzing Stock Buybacks For Value Creation

    YCharts
  8. Top Five Guru-Owned Mid Cap Stocks

    GuruFocus
  9. Bloody Disruption: New Threat to Quest, LabCorp

    YCharts
  10. Mid-Day Market Movers For Monday, June 16, 2014

    Benzinga
  11. Conferences/Events Scheduled for Week of Jun. 9th to Jun. 13th

    Benzinga
  12. Morning Coffee: Widely Held Guru Stocks Near Historic Low P/S

    GuruFocus
  13. UPDATE: Bank Of America Upgrades Quest Diagnostics On Near-Term Outlook

    Benzinga
  14. Benzinga's Top Upgrades

    Benzinga
  15. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  16. Morning Coffee: Widely Held Guru Stocks Trading Near Historical Low P/S

    GuruFocus
  17. Morning Coffee: Widely Held Guru Stocks Near Historical Low P/B

    GuruFocus
  18. Tool: Find Stocks Benefitting From Smart Buybacks

    YCharts
  19. Earnings Scheduled For April 24, 2014

    Benzinga
  20. Quest Diagnostics Extends Partnership with Steward Health Care System

    Benzinga
  21. Medical Diagnostic Labs Facing Medicare Headwinds

    GuruFocus
  22. Morning Coffee: Stocks at Historical Low P/B and P/S

    GuruFocus
  23. Myriad Stock Tumbles After Court Allows Rival To Sell

    IBD
  24. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  25. Diamond Hill Capital Comments on Quest Diagnostics

    GuruFocus
  26. Stocks Hitting 52-Week Lows

    Benzinga
  27. UPDATE: Quest Diagnostics Posts Higher Q4 Profit, Issues Downbeat 2014 ...

    Benzinga
  28. Earnings Scheduled For January 30, 2014

    Benzinga
  29. Quest Buys Solstas Lab for $570M

    FoxBusiness
  30. It's Time to Follow Chris Davis and Buy Laboratory Corp

    GuruFocus
  31. Quest Diagnostics Adds Timothy L. Main to Board of Directors

    Benzinga
  32. UC San Francisco, Quest Diagnostics Form Collaboration

    Benzinga
  33. Myriad Price Cut Reflects Changing Gene-Test Industry

    IBD
  34. 5 Leadership Traits That Stock Investors Should Look For

    GuruFocus
  35. Numerous Gurus Hold IDCC, DGX, PTR at 10-Year Low P/B

    GuruFocus
  36. Myriad Hit By Downgrades After Reimbursement Cut

    IBD
  37. UPDATE: JMP Securities Initiates Coverage on Quest Diagnostics on Multiple ...

    Benzinga
  38. Hologic's Opportunity (Icahn Sees It. Do You?)

    GuruFocus
  39. DGX, STO, LSE:DOM - Gurus Hold Stocks Traded at 10-Year Low P/B

    GuruFocus
  40. Quest, LabCorp Plunge: Buying Opportunity?

    YCharts
  41. UPDATE: Morgan Stanley Removes PT on Quest Diagnostics on Model Update ...

    Benzinga
  42. UPDATE: Bank of America Downgrades Quest Diagnostics on Reduced 2014 EPS ...

    Benzinga
  43. Benzinga's Top Downgrades

    Benzinga
  44. Myriad Genetics Sued On Gene Patents; Stock Falls

    IBD
  45. Dividends Are Still The Yield That Matters

    YCharts
  46. Benzinga's Top Initiations

    Benzinga
  47. Danaher Hits New High After Q3 Earnings Beat

    IBD
  48. Earnings Scheduled For October 17, 2013

    Benzinga
  49. J&J Q3 Results: Strong In Pharma, So-So Elsewhere

    IBD
  50. UPDATE: Citigroup Lowers PT on Quest Diagnostics Following Disappointing ...

    Benzinga
Trading Center